Safety and preliminary antitumor activity of CEP-18770 reported in first-in-human study Dec. 13, 2010
MN-100 inhibits growth of MM xenografts and alleviates tumor-associated immune suppression in vivo Dec. 13, 2010
First-in-human trial supports benefits of BKT-140 in autologous transplantation for multiple myeloma Dec. 10, 2010